Gameto is a female-led biotech company developing treatment solutions to improve women's reproductive health throughout their lives: from egg freezing, infertility, and diseases of the reproductive years to menopause and conditions that occur afterward.
We are building treatment solutions to provide better options for women.
Women's reproductive health is an underdeveloped area within the healthcare industry.
Despite a growing global infertility crisis, female reproductive therapies have remained largely unimproved since inception decades ago.
Until now.
We’ve developed a platform that is broadly applicable and has the potential to solve many gaps in the women’s health space. Our first focus is filling the massive gaps in the fertility space.
Creating transformative solutions for women’s health
The first application of our technology aims to improve the current IVF and egg freezing landscape. We are advancing technology in a space that has been virtually untouched since inception.
Scientists, Innovators, and Biotechnology Entrepreneurs
Our female-led team understands the burden women take when embarking on their reproductive journeys and is passionate about improving it. Our mission to redefine women's health guides everything we do.
Gameto lands ARPA-H funding to combat menopause with cell therapy
News
Gameto Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
News
Gameto Presents New Data on In Vitro Maturation Product Candidate Fertilo During Seven Presentations at the 2024 American Society for Reproductive Medicine (ASRM) Annual Meeting
News
Gameto Selected for Seven Presentations at the American Society for Reproductive Medicine (ASRM) 2024 Annual Meeting
News
Gameto Appoints Dr. Jaime Knopman as Chairwoman of Clinical Advisory Board to Guide Clinical Strategy and Innovation in Women’s Health
News
Gameto Appoints Dr. Ghassan (Gus) Haddad as Chief Medical Officer to Lead Clinical Development of Fertilo, a Cell-Based Treatment for IVF and Egg Freezing
News
Dawn of the Silicon Valley Superbaby
News
Gameto Presents Data Supporting Manufacturing Process for its In Vitro Maturation Solution for Fertility Care at 2024 International Society for Stem Cell Research Annual Meeting
News
Gameto Presents Advances in Assisted Reproductive Technology at 2024 European Society of Human Reproduction and Embryology Annual Meeting
News
Blog Post: Fertility Treatments for the New Age
News
Gameto Secures $33M To Support Clinical Development of Fertility Treatment
News
Gameto Secures $33M in Series B Funding to Advance Novel In Vitro Fertilization Treatments
News
Gameto Raises $33M to Use Cell Engineering to Revolutionize Fertility Treatments
News
Gameto lands $33 million to advance women’s reproductive health
News
Gameto Raises $33 Million in Series B Financing to Advance Development and Commercialization of Novel Fertility Treatments
News
New York startup raises $33M for fertility treatment based on George Church’s stem cell research
News
Gameto Partners with Designer and Entrepreneur Stacey Bendet to Launch "Your Eggsperience Matters" Campaign to Raise Funds for RESOLVE During National Infertility Awareness Week
Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments
News
Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation
News
The next frontier in baby-making: More successful IVF, egg cells from men, and sperm cells from women? Biotech researchers aim to greatly expand reproductive opportunity.
News
Gameto Unveils New Data on In Vitro Maturation Product Candidate Fertilo During Four Presentations at the 2023 American Society for Reproductive Medicine
News
Gameto CEO Dr. Dina Radenkovic Recognized Among the Most Exceptional Entrepreneurs at the Goldman Sachs 2023 Builders and Innovators Summit
News
This biotech CEO decided to take her own (fertility) medicine
News
Gameto inks stem cell deal with Reprocell for female fertility program
REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs
News
What if We Could Get Rid of Menopause?
News
Gameto Named as 2023 Technology Pioneer by World Economic Forum
News
The Future of Fertility: A new crop of biotech startups want to revolutionize human reproduction.
News
Fertility treatments, closer to becoming cheaper?
News
This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF
News
Reimagining Infertility – An Interview with Christian Kramme
News
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
News
Why it is key to anticipate to preserve fertility?
News
A healthcare brand for women begins to take shape
News
Forbes Under 30 Healthcare 2023: Fighting Cancer, Expanding Access To Care And Protecting Women's Health
News
Inception Fertility Partners with Leading Technology Companies on Breakthrough Studies to Advance Reproductive Medicine
News
34 of the most promising women's health startups of 2022, according to VCs
News
Gameto, the biotech startup that uses cell engineering to treat with ovarian deterioration, arrives in Spain
News
Varsavsky chooses Madrid for the preclinical studies in Europe of his startup Gameto
News
Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics
News
Biotech Startup Gameto on Female Fertility and Aging
News
Gameto, the startup that seeks to delay menopause, lands in Spain
News
Is it Time to Cancel Menopause?
News
The 20(+1) under 40: Your guide to the next generation of biotech leaders
News
Why aren’t VCs funding more startups focused on menopause?
News
International Women’s Day: the wonderful women of longevity
News
Gameto founder talks menopause and female healthspan extension
News
Nature Is Sexist. Can Advances In Longevity Biotechnology Help Restore Reproductive Equality?
News
Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells
Scientific Publications
An integrated pipeline for mammalian genetic screening